Cardiovascular Problems with Lexiva (February 2010)

GlaxoSmithKline is notifying healthcare professionals that Lexiva (fosamprenavir calcium), a protease inhibitor, has been associated with an increased risk of myocardial infarction and dyslipidemia in HIV infected adults. The company’s letter recommends that patients have their cholesterol and triglycerides tested prior to starting therapy with Lexiva and at periodic intervals during treatment with the drug. […]

Cardiovascular Risk with Meridia (April 2010)

FDA is alerting healthcare professionals that Meridia (sibutramine) is contraindicated in patients with a history of cardiovascular disease because the drug increases their risk of heart attack and stroke. Meridia is used to manage obesity. In November 2009, an early communication from FDA reported preliminary study results suggesting that patients on Meridia had a greater […]

Carnitine Blend- Promote good cardiovascular health

The amino acid carnitine transports long-chain fatty acids into the energy-producing centers of the cells, the mitochondria, where 95% of cellular energy occurs. That is, carnitine helps convert fat into the energy needed to support the healthy functioning of the muscles, heart, brain, and sperm. Carnitine deficiencies can result from genetic disorders, diets high in […]

Cardiovascular Disease-Signs & Treatment- Live Case from NCVH

Dr. Craig Walker discusses a live case study from the New Cardiovascular Horizons conference, focusing on signs of cardiovascular disease and treatment options available through the latest and most advanced technology. Dr. Walker is founder of Cardiovascular Institute of the South and co-founder of the New Cardiovascular Horizons conference, the largest peripheral arterial disease (PAD) […]

Leicester Cardiovascular BRU – University of Leicester

Leicester Cardiovascular Biomedical Research Unit (BRU), at the Glenfield Hospital in Leicester, is part of a multi-million pound scheme to prevent, diagnose and treat ill-health and is one of 16 BRUs around England funded by the National Institute for Health Research (NIHR), a strategic research funding body within the NHS. The Glenfield Unit is a […]